Trial Updates

Prevention medication for pediatric migraine: should it be re-examined? 8:37
Prevention medication for pediatric migraine: should it be re-examined?
Massimiliano Valeriani • 15 Dec 2022
WHAT! trial of hormonal treatment for menstrual migraine 2:34
WHAT! trial of hormonal treatment for menstrual migraine
Gisela Terwindt • 12 Dec 2022
Preliminary data on the use of anti-CGRP mAbs in pediatric migraine 1:30
Preliminary data on the use of anti-CGRP mAbs in pediatric migraine
Massimiliano Valeriani • 15 Dec 2022
Does adenosine infusion induce migraine attacks in migraine patients? 3:40
Does adenosine infusion induce migraine attacks in migraine patients?
Janu Thuraiaiyah • 15 Dec 2022
The potential of nilotinib in the treatment of movement disorders 6:36
The potential of nilotinib in the treatment of movement disorders
Charbel Moussa • 28 Nov 2022
Psychopathological outcomes after epilepsy surgery in children 3:26
Psychopathological outcomes after epilepsy surgery in children
Carmen Barba • 2 Dec 2022
Temporal lobe epilepsy surgery outcomes in children versus adults 3:03
Temporal lobe epilepsy surgery outcomes in children versus adults
Carmen Barba • 2 Dec 2022
METEOROID: Phase III trial of satralizumab in patients with MOGAD 2:21
METEOROID: Phase III trial of satralizumab in patients with MOGAD
Kazuo Fujihara • 28 Oct 2022
World’s first trial of DMT-assisted psychedelic therapy in major depressive disorder: Phase I data 5:31
World’s first trial of DMT-assisted psychedelic therapy in major depressive disorder: Phase I data
Ellen James • 19 Oct 2022
WSC 2022 highlights: collateral flow in MR CLEAN-LATE 2:06
WSC 2022 highlights: collateral flow in MR CLEAN-LATE
Ana Catarina Fonseca • 28 Oct 2022
Findings from the PACIFIC-Stroke trial 4:19
Findings from the PACIFIC-Stroke trial
Valeria Caso • 23 Nov 2022
Restarting anticoagulation after ICH in patients with atrial fibrillation 3:35
Restarting anticoagulation after ICH in patients with atrial fibrillation
Hanne Christensen • 21 Oct 2022
Long-term results of ocrelizumab in treatment-naive patients with early relapsing MS 4:32
Long-term results of ocrelizumab in treatment-naive patients with early relapsing MS
João José Cerqueira • 28 Oct 2022
EVT as a treatment for MeVO: current guidelines and new studies 2:33
EVT as a treatment for MeVO: current guidelines and new studies
Nishita Singh • 25 Oct 2022
Update on huntingtin-lowering strategies under investigation for Huntington’s disease 4:14
Update on huntingtin-lowering strategies under investigation for Huntington’s disease
Ann Morgan et al. • 16 Sep 2022
Endovascular thrombectomy outcomes in patients with ischemic stroke due to medium vessel occlusion 3:56
Endovascular thrombectomy outcomes in patients with ischemic stroke due to medium vessel occlusion
Nishita Singh • 25 Oct 2022
The content of VJNeurology is intended for healthcare professionals